Impact: BARDA and the burn community continue to support thermal burn product development.
Partner: Clinical Synergies of New Medical Countermeasures in Burn Care
Product: Earlier this summer, a patient who presented with severe burns at MUSC was treated with two BARDA-supported burn products and the results were dramatic: less scarring, a shorter recovery time, and less pain than his surgeon anticipated. The surgeon used both an enzymatic debridement product and a product that promotes skin regeneration together to promote a better patient outcome. Since 2013, BARDA has been investing in cutting-edge medical countermeasures that address the continuum of care for burn patients so that medical professionals have the tools they need to treat patients with severe burns more effectively every day and to become better prepared to #SaveLives in a mass casualty incident.